This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? Lead Generation: Drive patient education sign-ups, HCP event registrations, and drug sample requests. Work with HIPAA-compliant ad partners to safeguard patient data. blogs or webinars).
Brands tiptoed around platforms like Facebook or Twitter, fearful of FDA repercussions, adverse event reporting, and lack of clear guidance. The emergence of HIPAA-compliant targeting technologies, HCP-specific segments, and improved analytics has made social platforms not just viable but essential for pharmaceutical marketing.
GoodRx is alleged to have shared ostensibly protected personal health information with other tech companies, used the data for ad targeting, allowed third-party use of the data, used a HIPAA seal on its site that misrepresented its compliance status, and failed to put other policies in place to protect the data.
They must be highly targeted, compliant with FDA and HIPAA guidelines, and designed to generate meaningful interactions rather than just impressions. Twitter Best for real-time updates, health awareness events, and expert opinions. Pharma marketers should align campaign goals with platform strengths to maximize ROI.
Short-Form Video Ads Quick, informative clips highlighting new drug mechanisms, clinical trial data, or FDA approvals. Violating HIPAA, FDA, or GDPR regulations can lead to heavy fines and reputational damage. HIPAA Compliance Ads must not target individuals based on sensitive health data without explicit consent.
Short-Form Video Ads Quick, informative clips highlighting new drug mechanisms, clinical trial data, or FDA approvals. Violating HIPAA, FDA, or GDPR regulations can lead to heavy fines and reputational damage. HIPAA Compliance Ads must not target individuals based on sensitive health data without explicit consent.
Provide quick updates on industry events, conferences, and regulatory news. Compliance Challenges and How to Overcome Them Pharma marketing on social media comes with strict regulations , including: FDA and EMA guidelines restricting direct-to-consumer advertising. HIPAA and GDPR laws protecting patient privacy.
Compliance-Ready Ad Strategies Pharma PPC campaigns must comply with FDA, HIPAA, and Googles healthcare advertising policies. For instance, a physician researching a new oncology treatment might leave your website without registering for an event. Retargeting ads help bring back users who showed interest but didnt take action.
Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3.
In December 2021, the US FDA issued a cross-center draft guidance with recommendations on the use of digital health technology tools (DHTTs) to acquire data remotely from participants in clinical investigations for medical products. Table 3: Example classification of DHTs. .
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content